北美泡腾片市场，按产品（药物、补充剂）、方法（干法、湿法制粒）、类型（处方药、非处方药）、适应症（利尿剂、疼痛管理、胃病、呼吸系统疾病等）、人群类型（儿童、成人）、应用（牙科产品、膳食补充剂、制药等）、最终用户（医院、专科诊所、家庭医疗保健等）、分销渠道（零售药店、药店、电子商务、大卖场和超市等）、国家（美国、加拿大、墨西哥）划分的行业趋势和预测（至 2028 年）
市场分析与洞察：北美泡腾片市场
预计北美泡腾片市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场将以 7.8% 的复合年增长率增长，预计到 2028 年将达到 58.4198 亿美元。医疗保健行业研发的增长和患有慢性疾病的老年人口的增加是预测期内推动市场需求的主要驱动力。
泡腾片是一种可以溶于水并释放二氧化碳的药片。这些药片是通过将成分压缩成致密的物质制成的，然后装入密封容器或泡罩包装中。当人们想要使用它们时，可以将药片放入水或其他液体中制成溶液。
泡腾片是一种在放入水或其他液体中时会迅速分解并释放二氧化碳的药片。快速分解会导致药片溶解在溶液中，并且通常会使溶液起泡或起泡。这些药片可用于给药各种药物。这些药片有几个优点。最大的优点之一是它们可以快速将药物输送到体内，因为药物是以易于吸收的溶液形式输送的。
老年人口的增加、人们对健康生活方式的认识不断提高、新产品研发的增加以及慢性病发病率的上升是预测期内推动泡腾片市场需求的主要驱动因素。然而，钠含量高和产品召回预计将阻碍预测期内泡腾片市场的增长。
泡腾片市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美泡腾片市场范围和市场规模
泡腾片市场根据产品、方法、类型、适应症、人群类型、应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品，北美泡腾片市场分为药物和补充剂。2021 年，由于人们对保持更健康生活方式的需求不断增长，以及泡腾片免疫增强剂作为补充剂的普及，补充剂领域占据了最高的市场份额。
- 根据方法，北美泡腾片市场分为干法和湿法制粒。2021 年，湿法制粒占据最高的市场份额，因为它易于操作，并提供不同类型的溶剂，从而简化泡腾片制造过程。
- 根据类型，北美泡腾片市场分为非处方药和处方药。2021 年，非处方药市场预计将占据北美泡腾片市场的主导地位，占据最高份额，因为大多数补充剂泡腾片都可以在柜台购买，此外，非处方抗酸药和止痛药的供应也推动了市场的增长。
- 根据适应症，北美泡腾片市场细分为利尿剂、疼痛管理、胃病、呼吸系统疾病和其他。2021 年，疼痛管理领域占据最高的市场份额，因为它们具有更快的吸收性和即时止痛性。
- 根据人口类型，北美泡腾片市场分为儿童和成人。2021 年，成人群体占据最高市场份额，因为与其他世代相比，这些片剂在成年人中更受欢迎。此外，患有慢性疾病的老年人口不断增加也在推动市场增长。
- 根据应用，北美泡腾片市场细分为牙科产品、膳食补充剂、药品和其他。2021 年，药品领域占据最高的市场份额，因为患有慢性疾病的患者人数不断增加，并且它在吞咽时具有优势。
- 根据最终用户，北美泡腾片市场分为医院、专科诊所、家庭医疗保健和其他。2021 年，由于非处方药和处方药的存在以及医院数量的增加，医院部门占据了最高的市场份额。
- 根据分销渠道，北美泡腾片市场分为零售药店、药店、电子商务、大卖场和超市等。2021 年，零售药店占据最高的市场份额，因为它们提供各种不同种类和口味的泡腾片。
泡腾片市场国家层面分析
对泡腾片市场进行分析，并根据疾病类型、严重程度、类型、药物类型、给药途径、最终用户和分销渠道提供市场规模信息。
北美泡腾片市场报告涵盖的国家包括美国、加拿大和墨西哥。
美国引领着北美泡腾片市场的增长，并且由于人们对更健康的生活方式的需求不断增长，补充剂领域在美国占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
患有慢性疾病的老年人口增加以及对保持更健康生活方式的需求不断增长，推动了泡腾片市场的增长
泡腾片市场还为您提供了每个国家泡腾片行业增长的详细市场分析，包括泡腾片药物销售、泡腾片技术进步的影响以及监管环境的变化及其对泡腾片市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和泡腾片市场份额分析
泡腾片市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对泡腾片市场的关注有关。
全球泡腾片市场的主要公司有拜耳股份公司、CHIESI SAS、Perrigo Company plc、葛兰素史克公司、SG Biopharm Pvt. Ltd.、Bliss GVS Pharma Limited、SCITECH、Vovantis Laboratories、Herbalife International of America, Inc.、利洁时集团、Nuun 等。
全球范围内的许多产品发布和协议也由各公司发起，这也加速了泡腾片市场的发展。
例如，
- 2021 年 2 月，拜耳公司启动了“营养缺口计划”，旨在扩大服务不足社区的矿物质和维生素获取渠道，以对抗营养不良。该计划使公司能够提高公司的整体收入并提升其在市场上的潜力。
- 2019 年 11 月，CHIESI SAS 荣获 2020 年多元化领袖奖，这使该公司成为意大利 70 家全球公司中的顶级全球公司之一。这使该公司获得了认可并拓展了其国际业务。>
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在泡腾片市场中的市场，这也为组织改善其泡腾片产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA EFFERVESCENT TABLET MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA EFFERVESCENT TABLET MARKET: REGULATIONS
5.1 REGULATIONS IN THE U.S.:
5.2 REGULATIONS IN EUROPE
5.3 REGULATIONS IN AUSTRALIA
5.4 REGULATIONS IN JAPAN
5.5 REGULATIONS IN CHINA
6 CONSUMER BEHAVIOUR ANALYSIS- NORTH AMERICA EFFERVESCENT TABLETS
6.1 CONSUMER PREFERENCE OVER ANOTHER FORM OF MEDICATION
6.2 REASON FOR CONSUMERS OPTING FOR EFFERVESCENT TABLET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN CHRONIC DISEASES
7.1.2 GROWTH OF R&D IN THE HEALTHCARE INDUSTRY
7.1.3 ADVANTAGES OF EFFERVESCENT PRODUCTS
7.1.4 INCREASE IN GERIATRIC POPULATION WITH CHRONIC DISEASES
7.1.5 RISE IN DEMAND FOR MAINTAINING A HEALTHIER LIFESTYLE
7.2 RESTRAINTS
7.2.1 DISADVANTAGES OF EFFERVESCENT TABLETS
7.2.2 INCREASE IN NUMBER OF PRODUCT RECALLS FOR EFFERVESCENT TABLETS
7.2.3 COMPLEX PRODUCTION PROCESS
7.2.4 EXPENSIVE PRODUCT AS COMPARE TO CONVENTIONAL TABLETS
7.3 OPPORTUNITIES
7.3.1 RISE IN DISPOSABLE INCOMES
7.3.2 STRATEGIC INITIATIVE BY KEY MARKET PLAYERS
7.3.3 RISE IN DEMAND FOR EFFERVESCENT TABLET
7.4 CHALLENGES
7.4.1 SHORTAGE OF AVAILABILITY OF THE EFFERVESCENT PRODUCTS IN REMOTE AND UNDERDEVELOPED REGIONS
7.4.2 LIMITATION ASSOCIATED WITH THE PRESENCE OF HIGH SODIUM CONTENT
8 IMPACT OF COVID-19 ON NORTH AMERICA EFFERVESCENT TABLET MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS BY MANUFACTURERS
8.5 CONCLUSION
9 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY PRODUCTS
9.1 OVERVIEW
9.2 SUPPLEMENTS
9.2.1 VITAMINS
9.2.2 MINERALS
9.3 MEDICATION
9.3.1 ANALGESICS
9.3.2 ANTACIDS
10 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY METHOD
10.1 OVERVIEW
10.2 WET GRANULATION
10.2.1 FLUID BED SPRAY GRANULATION
10.2.2 ORGANIC SOLVENTS
10.2.3 WATER
10.3 DRY METHOD
11 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY TYPE
11.1 OVERVIEW
11.2 OVER THE COUNTER
11.3 PRESCRIPTION
12 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY INDICATION
12.1 OVERVIEW
12.2 PAIN MANAGEMENT
12.3 GASTRIC DISORDER
12.4 RESPIRATORY DISEASES
12.5 DIURETICS
12.6 OTHERS
13 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY POPULATION TYPE
13.1 OVERVIEW
13.2 ADULTS
13.3 CHILDREN
14 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 PHARMACEUTICAL
14.3 DIETARY SUPPLEMENTS
14.4 DENTAL PRODUCTS
14.5 OTHERS
15 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS
15.3 SPECIALTY CLINICS
15.4 HOME HEALTHCARE
15.5 OTHERS
16 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 RETAIL PHARMACIES
16.3 DRUG STORES
16.4 E-COMMERCE
16.5 HYPERMARKET & SUPERMARKETS
16.6 OTHERS
17 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY REGION
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
18 NORTH AMERICA EFFERVESCENT TABLET MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
19 SWOT
20 COMPANY PROFILE
20.1 GLAXOSMITHKLINE PLC
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 BAYER AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 RECKITT BENCKISER GROUP PLC
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENTS
20.4 PERRIGO COMPANY PLC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENTS
20.5 HERBALIFE INTERNATIONAL OF AMERICA INC
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENTS
20.6 SWISSE WELLNESS PTY LTD
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENTS
20.7 ALPEX
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 BLISS GVS PHARMA LIMITED
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENTS
20.9 CHIESI SAS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 DIETFARM
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 HERMES ARZNEIMITTEL
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 NUUN
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENTS
20.13 NATUR PRODUKT ZDROVIT SP. Z O.O.
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 SCITECH
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENTS
20.15 S. G. BIOPHARMA PVT LTD.
20.15.1 COMPANY SNAPSHOT
20.15.2 PRODUCT PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 VITABIOTICS LTD.
20.16.1 COMPANY SNAPSHOT
20.16.2 PRODUCT PORTFOLIO
20.16.3 RECENT DEVELOPMENT
20.17 VOVANTIS LABORATORIES
20.17.1 COMPANY SNAPSHOT
20.17.2 PRODUCT PORTFOLIO
20.17.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA MEDICATION IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA MEDICATION IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA DRY METHOD IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA OVER THE COUNTER IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PRESCRIPTION IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA PAIN MANAGEMENT IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA GASTRIC DISORDER IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA RESPIRATORY DISEASES IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA DIURETICS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA OTHERS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ADULTS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA CHILDREN IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA PHARMACEUTICAL IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA DIETARY SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA DENTAL PRODUCTSTS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA OTHERS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA HOSPITALS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA SPECIALTY CLINICS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA HOME HEALTHCARE IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA RETAIL PHARMACIES IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA DRUG STORE IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA E-COMMERCE IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA HYPERMARKET & SUPERMARKETS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN EFFERVESCENT TABLET MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA MEDICATION IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 U.S. EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 51 U.S. SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 52 U.S. MEDICATION IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 53 U.S. EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 54 U.S. WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 55 U.S. EFFERVESCENT TABLET MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.S. EFFERVESCENT TABLET MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 57 U.S. EFFERVESCENT TABLET MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 58 U.S. EFFERVESCENT TABLET MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 U.S. EFFERVESCENT TABLET MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 U.S. EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 CANADA EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 62 CANADA SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 63 CANADA MEDICATION IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 64 CANADA EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 65 CANADA WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 66 CANADA EFFERVESCENT TABLET MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 CANADA EFFERVESCENT TABLET MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 68 CANADA EFFERVESCENT TABLET MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 69 CANADA EFFERVESCENT TABLET MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 CANADA EFFERVESCENT TABLET MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 71 CANADA EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 72 MEXICO EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 73 MEXICO SUPPLEMENTS IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 74 MEXICO MEDICATION IN EFFERVESCENT TABLET MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 75 MEXICO EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 76 MEXICO WET GRANULATION IN EFFERVESCENT TABLET MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 77 MEXICO EFFERVESCENT TABLET MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 MEXICO EFFERVESCENT TABLET MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 79 MEXICO EFFERVESCENT TABLET MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 80 MEXICO EFFERVESCENT TABLET MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 MEXICO EFFERVESCENT TABLET MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 82 MEXICO EFFERVESCENT TABLET MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA EFFERVESCENT TABLET MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EFFERVESCENT TABLET MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EFFERVESCENT TABLET MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EFFERVESCENT TABLET MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EFFERVESCENT TABLET MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EFFERVESCENT TABLET MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA EFFERVESCENT TABLET MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA EFFERVESCENT TABLET MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA EFFERVESCENT TABLET MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA EFFERVESCENT TABLET MARKET: SEGMENTATION
FIGURE 11 INCREASE IN CHRONIC DISEASES AND R&D ACTIVITIES ARE EXPECTED TO DRIVE THE NORTH AMERICA EFFERVESCENT TABLET MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 DIAGNOSIS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EFFERVESCENT TABLET MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA EFFERVESCENT TABLET MARKET
FIGURE 14 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY PRODUCTS, 2020
FIGURE 15 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)
FIGURE 16 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY PRODUCTS, CAGR (2021-2028)
FIGURE 17 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 18 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY METHOD, 2020
FIGURE 19 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY METHOD, 2020-2028 (USD MILLION)
FIGURE 20 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY METHOD, CAGR (2021-2028)
FIGURE 21 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY METHOD, LIFELINE CURVE
FIGURE 22 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY TYPE, 2020
FIGURE 23 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 24 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 25 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY INDICATION, 2020
FIGURE 27 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY INDICATION, 2020-2028 (USD MILLION)
FIGURE 28 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY INDICATION, CAGR (2021-2028)
FIGURE 29 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 30 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY POPULATION TYPE, 2020
FIGURE 31 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)
FIGURE 32 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY POPULATION TYPE, CAGR (2021-2028)
FIGURE 33 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY APPLICATION, 2020
FIGURE 35 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 36 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY END USER, 2020
FIGURE 39 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 40 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 44 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 NORTH AMERICA EFFERVESCENT TABLET MARKET: SNAPSHOT (2020)
FIGURE 47 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY COUNTRY (2020)
FIGURE 48 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 NORTH AMERICA EFFERVESCENT TABLET MARKET: BY PRODUCTS (2021-2028)
FIGURE 51 NORTH AMERICA EFFERVESCENT TABLET MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
